Folstein Scoring and Interpretation 3

Question 1

A decline of 3 to 4 points on serial MMSE testing is generally considered clinically significant because it suggests what?

Accepted Answer

Meaningful cognitive deterioration beyond expected change

Answer

Normal aging

Answer

Test-retest variability only

Answer

Medication side effects only

Question 2

How often is the MMSE typically re-administered to monitor dementia progression?

Accepted Answer

Every 6 to 12 months

Answer

Weekly

Answer

Monthly

Answer

Only at diagnosis

Question 3

Which MMSE score range is most commonly associated with mild dementia?

Accepted Answer

18–23

Answer

0–9

Answer

10–17

Answer

24–30

Question 4

What is the generally accepted minimum MMSE score indicating no significant cognitive impairment in clinical screening?

Accepted Answer

24

Answer

20

Answer

22

Answer

27

Question 5

An MMSE score of 0–9 indicates what severity level of cognitive impairment?

Accepted Answer

Severe

Answer

Mild

Answer

Moderate

Answer

Borderline

Question 6

How is the MMSE most appropriately used in a dementia diagnosis?

Accepted Answer

As a screening tool that informs but does not replace full clinical evaluation

Answer

As the sole diagnostic criterion

Answer

As a replacement for neuroimaging

Answer

As the only assessment needed after age 65